Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Nephrology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Nephrology Other
    Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study - (BMJ)
    FDA Approves Ferumoxytol for Iron Deficiency Anaemia in Patients With CKD - (DGNews)
    Gadolinium-Based Contrast Agents Alone Not Sufficient to Cause Nephrogenic Systemic Fibrosis - (DGNews)
    Contrast-Induced Kidney Damage Can Cause Long-Term Health Problems - (DGNews)
    Roux-en-Y Weight Loss Surgery Raises Kidney Stone Risk - (DGNews)

    News archive

     Recent webcasts/CME - Nephrology Other

    Webcasts/CME archive

     Recent cases - Nephrology Other
      Medical Management of a Pregnancy Woman with Moderate Renal Insufficiency and Superimposed Preclampsia
      A 72-Year-Old Man with a Purpuric Rash
      Choroidopathy and Kidney Disease: A Case Report and Review of the Literature
      Medullary Sponge Kidney Presenting in a Neonate with Distal Renal Tubular Acidosis and Failure to Thrive: A Case Report
      Hepatitis Following Famotidine: A Case Report

      Cases archive
        




      my personal edition > nephrology other > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Calcineurin Inhibitor Sparing Using Mycophenolate May Play a Key Role in Kidney Transplantation: Presented at ASN

      By Maggie Schwarz

      PHILADELPHIA -- November 9, 2008 -- Adjunctive mycophenolate used in a calcineurin inhibitor-sparing strategy may play an important role in kidney transplant recipients, according to research presented at Renal Week 2008, the American Society of Nephrology (ASN) annual meeting.

      Coinvestigator Keith Wheatley, MD, University of Birmingham, Birmingham, United Kingdom, was part of a team that performed a systematic review and meta-analysis of 19 randomized controlled trials in which calcineurin inhibitor sparing was accompanied by continuation of mycophenolate or conversion to this agent and compared with standard or higher-dose calcineurin inhibitor therapy. Dr. Wheatley reported the results here at a poster presentation on November 8.

      The trials analyzed included 3,312 renal transplant recipients who were followed for a median of 12 months. The following subgroups were studied: elective calcineurin inhibitor sparing beyond 2 months after transplantation; calcineurin inhibitor sparing for transplant dysfunction; and de novo calcineurin inhibitor sparing.

      Calcineurin inhibitor sparing improved glomerular filtration rate significantly (weighted mean difference of 4.4 mL/min, P < .001), with evidence of improved graft survival (P = .06). Acute rejection rates were increased only following elective calcineurin inhibitor elimination (P < .001).

      There were no significant differences in mortality, malignancy, or incidence of infections.

      Dr. Wheatley concluded that calcineurin inhibitor-sparing strategies using adjunctive mycophenolate may play an important role in kidney transplant recipients, such as offering improvements in short-term graft function and possibly graft survival. He added that refinement of protocols for the elimination of calcineurin inhibitor may help to reduce the risk of rejection.

      [Presentation title: Kidney Transplantation and Calcineurin Inhibitor Sparing With Adjunctive Mycophenolate: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Abstract SA-PO2551]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send